Skip to main content

ADVERTISEMENT

Sheela Rao, MBBS, MD

Sheela Rao, MBBS, MD
Conference Coverage
09/16/2024
Sheela Rao, MBBS, MD, discusses results from the phase 3 POD1UM-303/InterAACT 2 study which showed encouraging efficacy with retifanlimab added to standard of care chemotherapy in patients with locally recurrent or metastatic squamous cell...
Sheela Rao, MBBS, MD, discusses results from the phase 3 POD1UM-303/InterAACT 2 study which showed encouraging efficacy with retifanlimab added to standard of care chemotherapy in patients with locally recurrent or metastatic squamous cell...
Sheela Rao, MBBS, MD, discusses...
09/16/2024
Oncology